BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 17563058)

  • 1. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome.
    Skov V; Glintborg D; Knudsen S; Jensen T; Kruse TA; Tan Q; Brusgaard K; Beck-Nielsen H; Højlund K
    Diabetes; 2007 Sep; 56(9):2349-55. PubMed ID: 17563058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.
    Højlund K; Glintborg D; Andersen NR; Birk JB; Treebak JT; Frøsig C; Beck-Nielsen H; Wojtaszewski JF
    Diabetes; 2008 Feb; 57(2):357-66. PubMed ID: 17977950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose.
    Tan BK; Adya R; Farhatullah S; Lewandowski KC; O'Hare P; Lehnert H; Randeva HS
    Diabetes; 2008 Apr; 57(4):801-8. PubMed ID: 18174521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
    Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
    Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling following local muscle inactivity in humans provides new perspective on diabetes-related genes.
    Timmons JA; Norrbom J; Schéele C; Thonberg H; Wahlestedt C; Tesch P
    Genomics; 2006 Jan; 87(1):165-72. PubMed ID: 16326070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients.
    Takamura T; Misu H; Matsuzawa-Nagata N; Sakurai M; Ota T; Shimizu A; Kurita S; Takeshita Y; Ando H; Honda M; Kaneko S
    Obesity (Silver Spring); 2008 Dec; 16(12):2601-9. PubMed ID: 18846047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome.
    Skov V; Glintborg D; Knudsen S; Tan Q; Jensen T; Kruse TA; Beck-Nielsen H; Højlund K
    PLoS One; 2008 Jun; 3(6):e2466. PubMed ID: 18560589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of insulin deprivation on muscle mitochondrial ATP production and gene transcript levels in type 1 diabetic subjects.
    Karakelides H; Asmann YW; Bigelow ML; Short KR; Dhatariya K; Coenen-Schimke J; Kahl J; Mukhopadhyay D; Nair KS
    Diabetes; 2007 Nov; 56(11):2683-9. PubMed ID: 17660267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins.
    Ling C; Poulsen P; Carlsson E; Ridderstråle M; Almgren P; Wojtaszewski J; Beck-Nielsen H; Groop L; Vaag A
    J Clin Invest; 2004 Nov; 114(10):1518-26. PubMed ID: 15546003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes.
    Finck BN; Bernal-Mizrachi C; Han DH; Coleman T; Sambandam N; LaRiviere LL; Holloszy JO; Semenkovich CF; Kelly DP
    Cell Metab; 2005 Feb; 1(2):133-44. PubMed ID: 16054054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
    Bitar MS; Al-Saleh E; Al-Mulla F
    Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo.
    Rajkhowa M; Brett S; Cuthbertson DJ; Lipina C; Ruiz-Alcaraz AJ; Thomas GE; Logie L; Petrie JR; Sutherland C
    Biochem J; 2009 Mar; 418(3):665-71. PubMed ID: 19053948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of electron transport chain genes in visceral adipose tissue in type 2 diabetes independent of obesity and possibly involving tumor necrosis factor-alpha.
    Dahlman I; Forsgren M; Sjögren A; Nordström EA; Kaaman M; Näslund E; Attersand A; Arner P
    Diabetes; 2006 Jun; 55(6):1792-9. PubMed ID: 16731844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia.
    Asmann YW; Stump CS; Short KR; Coenen-Schimke JM; Guo Z; Bigelow ML; Nair KS
    Diabetes; 2006 Dec; 55(12):3309-19. PubMed ID: 17130474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling.
    Wood JR; Ho CK; Nelson-Degrave VL; McAllister JM; Strauss JF
    J Reprod Immunol; 2004 Aug; 63(1):51-60. PubMed ID: 15284005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.